Related Experiment Video
Updated: Apr 16, 2026

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia
Published on: July 25, 2017
Challenge to the suppression of tumor growth by the β4-galactosyltransferase genes
1Laboratory of Glycobiology, Graduate School of Engineering, Nagaoka University of Technology.
Abstract:
It has been well established that structural changes in glycans attached to proteins and lipids are associated with malignant transformation of cells. We focused on galactose residues among the sugars since they are involved in the galectin-mediated biology, and many carbohydrate antigens are frequently expressed on this sugar. We found changes in the expression of the β4-galactosyltransferase (β4GalT) 2 and 5 genes in cancer cells: decreased expression of the β4GalT2 gene and increased expression of the β4GalT5 gene. The growth of mouse melanoma cells showing enhanced expression of the β4GalT2 gene or reduced expression of the β4GalT5 gene is inhibited remarkably in syngeneic mice. Tumor growth inhibition is probably caused by the induction of apoptosis, inhibition of angiogenesis, and/or reduced MAPK signals. Direct transduction of human β4GalT2 cDNA together with the adenovirus vector into human hepatocellular carcinoma cells grown in SCID mice results in marked growth retardation of the tumors. β4GalT gene-transfer appears to be a potential tool for cancer therapy.
Insights
Altering beta-4-galactosyltransferase (β4GalT) gene expression, specifically β4GalT2 and β4GalT5, impacts cancer cell growth. Modulating these genes shows potential for novel cancer therapies by inhibiting tumor progression.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Aberrant glycan structures on proteins and lipids are hallmarks of cancer.
- Galactose residues are crucial in galectin biology and cancer antigen expression.
Purpose of the Study:
- To investigate the role of beta-4-galactosyltransferase (β4GalT) 2 and 5 genes in cancer.
- To evaluate the therapeutic potential of modulating β4GalT gene expression in cancer treatment.
Main Methods:
- Analyzing β4GalT2 and β4GalT5 gene expression in cancer cells.
- Modifying β4GalT gene expression in mouse melanoma and human hepatocellular carcinoma cells.
- Utilizing syngeneic mice and SCID mice models for tumor growth studies.
- Employing adenovirus vectors for gene transduction.
Main Results:
- Decreased β4GalT2 and increased β4GalT5 gene expression observed in cancer cells.
- Enhanced β4GalT2 or reduced β4GalT5 expression inhibited mouse melanoma growth.
- Tumor growth inhibition correlated with apoptosis induction, reduced angiogenesis, and MAPK signaling.
- Transduction of human β4GalT2 cDNA into hepatocellular carcinoma cells retarded tumor growth.
Conclusions:
- β4GalT gene expression is altered during malignant transformation.
- Modulating β4GalT2 and β4GalT5 expression inhibits tumor growth through multiple mechanisms.
- β4GalT gene transfer represents a promising strategy for cancer therapy.
More Related Videos
08:42Tracing Gene Expression Through Detection of β-galactosidase Activity in Whole Mouse Embryos
Published on: June 26, 2018
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Tumor Immunotherapy
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...